Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Past and present attempts to prevent radiocontrast nephropathy.

Bailey SR.

Rev Cardiovasc Med. 2001;2 Suppl 1:S14-8. Review.

PMID:
12439363
2.

Radiocontrast-induced acute renal failure: allocations and outcomes.

Mehran R, Ashby DT.

Rev Cardiovasc Med. 2001;2 Suppl 1:S9-13. Review.

PMID:
12439362
3.

Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.

Stone GW, Tumlin JA, Madyoon H, Lepor NE, McCullough PA, Mathur VS, Murray PT, O'Neill WW.

Rev Cardiovasc Med. 2001;2 Suppl 1:S31-6.

PMID:
12439366
4.

N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.

Duong MH, MacKenzie TA, Malenka DJ.

Catheter Cardiovasc Interv. 2005 Apr;64(4):471-9. Review.

PMID:
15789388
5.

Radiocontrast-induced nephropathy.

Asif A, Preston RA, Roth D.

Am J Ther. 2003 Mar-Apr;10(2):137-47. Review.

PMID:
12629594
6.

Prevention of radiocontrast-induced nephropathy.

Baker CS.

Catheter Cardiovasc Interv. 2003 Apr;58(4):532-8. Review. No abstract available.

PMID:
12652507
7.

Radiocontrast nephropathy: the dye is not cast.

Lepor NE.

Rev Cardiovasc Med. 2000 Summer;1(1):43-54. Review.

PMID:
12457151
8.

Current trials of interventions to prevent radiocontrast-induced nephropathy.

Asif A, Garces G, Preston RA, Roth D.

Am J Ther. 2005 Mar-Apr;12(2):127-32. Review.

PMID:
15767830
9.

Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.

Mathur VS.

Rev Cardiovasc Med. 2001;2 Suppl 1:S4-8. Review.

PMID:
12439361
10.
11.

Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis.

Joannidis M, Schmid M, Wiedermann CJ.

Wien Klin Wochenschr. 2008;120(23-24):742-8. doi: 10.1007/s00508-008-1117-z.

PMID:
19122985
12.

Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.

Itoh Y, Yano T, Sendo T, Oishi R.

J Pharmacol Sci. 2005 Apr;97(4):473-88. Review.

13.

Prevention of radiocontrast-induced nephropathy.

Asif A, Epstein M.

Am J Kidney Dis. 2004 Jul;44(1):12-24. Review.

PMID:
15211433
14.

Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.

Asif A, Epstein DL, Epstein M.

J Clin Pharmacol. 2004 Dec;44(12):1342-51. Review.

PMID:
15545304
15.

Prevention of intravenous contrast-induced nephropathy in hospital inpatients.

Kakkar R, Sobieszczyk P, Binkert CA, Faxon DP, Mortele KJ, Singh AK.

Crit Pathw Cardiol. 2008 Mar;7(1):1-4. doi: 10.1097/HPC.0b013e318163f258. Review.

PMID:
18458660
16.

Contrast nephropathy : an evidence-based approach to prevention.

Kandzari DE, Rebeiz AG, Wang A, Sketch MH Jr.

Am J Cardiovasc Drugs. 2003;3(6):395-405. Review.

PMID:
14728060
17.

[Nephropathy caused by radiocontrast media].

Kolarz M, Sułowicz W.

Przegl Lek. 2005;62(5):292-8. Review. Polish.

PMID:
16334535
18.

Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view.

Idé JM, Lancelot E, Pines E, Corot C.

Invest Radiol. 2004 Mar;39(3):155-70. Review.

PMID:
15076008
19.

Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.

Goldenberg I, Shechter M, Matetzky S, Jonas M, Adam M, Pres H, Elian D, Agranat O, Schwammenthal E, Guetta V.

Eur Heart J. 2004 Feb;25(3):212-8. Review.

20.

Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy.

Forman JP.

N Engl J Med. 2004 Feb 19;350(8):836-8; author reply 836-8. No abstract available.

PMID:
14978836
Items per page

Supplemental Content

Support Center